Francisco Silva insider trades: BioRestorative Therapies (BRTX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Francisco reports to the SEC
Open-market buys and sales
19 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 9, 2024 | BRTX | ↑ Buy | 8,308 | $1.23 | $10K | Direct | Apr 10, 2024 (1d) |
| Aug 31, 2023 | BRTX | ↑ Buy | 4,954 | $2.22 | $11K | Direct | Aug 31, 2023 (0d) |
| Mar 31, 2023 | BRTX | ↑ Buy | 747 | $3.56 | $3K | Direct | Apr 4, 2023 (4d) |
| Nov 21, 2022 | BRTX | ↑ Buy | 943 | $2.62 | $2K | Direct | Nov 21, 2022 (0d) |
| Oct 12, 2022 | BRTX | ↑ Buy | 725 | $3.39 | $2K | Direct | Oct 12, 2022 (0d) |
| Oct 11, 2022 | BRTX | ↑ Buy | 806 | $3.69 | $3K | Direct | Oct 12, 2022 (1d) |
| Aug 29, 2022 | BRTX | ↑ Buy | 5,416 | $3.28 | $18K | Direct | Sep 9, 2022 (11d) |
| Aug 29, 2022 | BRTX | ↑ Buy | 307 | $3.32 | $1K | Ira | Sep 9, 2022 (11d) |
| Aug 26, 2022 | BRTX | ↓ Sell | 3,958 | $3.39 | $13K | Direct | Sep 9, 2022 (14d) |
| Nov 19, 2021 | BRTX | ↑ Buy | 4,000 | $6.66 | $27K | Ira | Nov 22, 2021 (3d) |
| Nov 16, 2021 | BRTX | ↑ Buy | 7,826 | $6.73 | $53K | Ira | Nov 16, 2021 (0d) |
| Sep 4, 2019 | BRTX | ↑ Buy | 20,955 | $0.24 | $5K | Direct | Sep 6, 2019 (2d) |
| Aug 30, 2019 | BRTX | ↑ Buy | 18,000 | $0.28 | $5K | Direct | Sep 3, 2019 (4d) |
| Aug 26, 2019 | BRTX | ↑ Buy | 3,500 | $0.29 | $1K | Ira | Aug 28, 2019 (2d) |
| Aug 26, 2019 | BRTX | ↑ Buy | 4,000 | $0.25 | $1K | Direct | Aug 28, 2019 (2d) |
| Aug 22, 2019 | BRTX | ↑ Buy | 8,928 | $0.28 | $2K | Direct | Aug 23, 2019 (1d) |
| Aug 22, 2019 | BRTX | ↑ Buy | 8,446 | $0.23 | $2K | Ira | Aug 23, 2019 (1d) |
| Feb 9, 2017 | BRTX | ↑ Buy | 4,075 | $4.33 | $18K | Direct | Mar 1, 2017 (20d) |
| Jun 11, 2014 | BRTX | ↑ Buy | 170 | $10.07 | $2K | Ira | Mar 1, 2017 (994d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Francisco Silva's insider trades
Francisco Silva is VP of Research and Development at BioRestorative Therapies (BRTX). Since Jun 11, 2014, Francisco has reported 18 open-market purchases worth $166K and 1 sale worth $13K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (22 filings), shares returned to the company (4 filings), shares withheld for taxes (3 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BRTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.